CVS Health Co. (NYSE:CVS) Shares Sold by Trillium Asset Management LLC

Trillium Asset Management LLC trimmed its position in CVS Health Co. (NYSE:CVS) by 1.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 147,892 shares of the pharmacy operator’s stock after selling 1,603 shares during the period. Trillium Asset Management LLC’s holdings in CVS Health were worth $11,796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CVS. Atticus Wealth Management LLC lifted its position in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares during the period. USA Financial Formulas boosted its stake in shares of CVS Health by 573.2% in the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 321 shares during the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in CVS Health during the fourth quarter worth about $32,000. Creekmur Asset Management LLC purchased a new position in CVS Health during the fourth quarter valued at approximately $34,000. Finally, Steph & Co. lifted its holdings in CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CVS shares. UBS Group cut shares of CVS Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $85.00 to $60.00 in a research note on Thursday, May 2nd. JPMorgan Chase & Co. lowered their target price on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research note on Thursday, May 30th. Bank of America lowered their price target on CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. The Goldman Sachs Group reduced their target price on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Finally, Baird R W raised shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Eleven equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $75.05.

CVS Health Trading Down 0.6 %

Shares of CVS stock traded down $0.34 on Friday, hitting $59.57. 6,582,282 shares of the stock traded hands, compared to its average volume of 11,677,024. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The stock has a market capitalization of $74.78 billion, a PE ratio of 10.47, a PEG ratio of 0.59 and a beta of 0.52. The firm’s 50-day moving average price is $58.56 and its two-hundred day moving average price is $68.37. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period last year, the company earned $2.20 EPS. The business’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, analysts anticipate that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Monday, July 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.47%. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.

Insider Buying and Selling

In other news, Director Edward J. Ludwig bought 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the acquisition, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.24% of the stock is owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.